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Background.With the introduction of three-dimensional (3D) ultrasound it has become possible to measure volumes. The relative
increase in embryonic volume (EV) is much larger than that of the crown-rump length (CRL) over the same time period. We
examined whether EV is a better parameter to determine growth restriction in fetuses with structural congenital abnormalities.
Study Design, Subjects, and Outcome Measures. CRL and EV were measured using a Virtual Reality (VR) system in prospectively
collected 3D ultrasound volumes of 56 fetuses diagnosed with structural congenital abnormalities in the first trimester of pregnancy
(gestational age 7+5 to 14+5 weeks).MeasuredCRL and EVwere converted to 𝑧-scores and to percentages of the expectedmean using
previously published reference curves of euploid fetuses. The one-sample 𝑡-test was performed to test significance. Results.The EV
was smaller than expected for GA in fetuses with structural congenital abnormalities (−35% 𝑝 < 0.001, 𝑧-score −1.44 𝑝 < 0.001),
whereas CRL was not (−6.43% 𝑝 = 0.118, 𝑧-score −0.43 𝑝 = 0.605). Conclusions. CRL is a less reliable parameter to determine
growth restriction in fetuses with structural congenital abnormalities as compared with EV. By measuring EV, growth restriction
in first-trimester fetuses with structural congenital abnormalities becomes more evident and enables an earlier detection of these
cases.
1. Introduction
In the past decade prenatal screening has partly shifted from
the second trimester to the first trimester of pregnancy.
Because of vast improvements in imaging technology the
embryo and fetus in early pregnancy can be evaluated in
much more detail, allowing screening for structural abnor-
malities between 11 and 14 weeks GA [1–5]. A significant
proportion of major structural abnormalities can be detected
already in this period. In some cases, nonspecific findings,
like increased nuchal translucency, may be the first sign
for existing structural abnormalities, leading to additional
ultrasound examinations [6].
It is well known that first-trimester growth is associated
with pregnancy outcome [7–10] and that several factors like
maternal factors and dietary pattern influence first-trimester
growth [11–13]. Traditionally, first-trimester fetal growth has
been documented by two-dimensional (2D) crown-rump
length (CRL) measurements. With the introduction of three-
dimensional (3D) ultrasound it has become possible to
measure embryonic volumes (EV) [14]. Earlier studies show
that the relative increment of the EV is much larger than the
increment of the CRL during the same period [15]. Using an
innovative 3D Virtual Reality (VR) technique, Rousian et al.
demonstrated in this study that when the CRL doubles the
EV increases 6.5-fold. Volume measurement might therefore
enable earlier detection of fetal growth restriction in preg-
nancy. It is well known that too small CRL is a clinical predic-
tor for miscarriage, chromosomal abnormalities (especially
trisomy 18), and fetal growth restriction in the second and
third trimester of pregnancy [10, 16–19]. It has been suggested
that EV is smaller in aneuploid pregnancies and by using VR
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it was proven that, compared with CRL, EV was not only
smaller in trisomy 18 pregnancies but also in trisomy 21 and
trisomy 13 pregnancies [20, 21]. EV therefore turns out to
be a better parameter to detect growth restriction caused by
aneuploidy than CRL.
From these observations it is suspected that underlying
pathophysiological changes in these cases might influence
embryonic and early fetal growth. First-trimester growth
might also be impaired in pregnancies diagnosed with a
congenital abnormality. An association between the presence
of structural congenital abnormalities and second- and third-
trimester growth restriction is already known for a long time
[22–24].
The aim of this study is to examine the first-trimester
growth pattern in embryos and fetuses with structural
congenital abnormalities. CRL and EV measurements of
pregnancies with structural abnormalities were compared
with references values of CRL and EV in uncomplicated
pregnancies.
2. Methods
Between December 2008 and November 2013 transvaginal
three-dimensional (3D) ultrasound volumes were collected
of first-trimester pregnancies in which a structural congenital
abnormality was diagnosed (𝑁 = 71). Cases were collected at
the department of Obstetrics and Prenatal Medicine at Eras-
mus MC University Medical Center Rotterdam (𝑛 = 47) and
atHoˆpital PrincesseGraceMonaco (𝑛 = 15). Additional cases
(𝑁 = 9) were included from the Rotterdam Predict study
[11], a periconception cohort aimed at early pregnancy. Ultra-
sound scans were performed using the Voluson E8 Expert
system (GE Medical Systems, Zipf, Austria) by operators
experienced in collecting 3D ultrasound datasets. Structural
congenital abnormalities were all confirmed either during the
midpregnancy ultrasound scan, postpartum diagnosis, or a
pathological investigation after termination of pregnancy.
In spontaneously conceived pregnancies datingwas based
on the first day of the last menstrual period (LMP). When
the menstrual cycle was regular but >3 days different from
28 days the gestational age (GA) was adjusted for the cycle
length. In pregnancies conceived by in vitro fertilization
(IVF) with or without intracytoplasmic sperm injection
(ICSI) GA was calculated from the day of oocyte retrieval
plus 14 days. In pregnancies originating from intrauterine
insemination GA was calculated based on the LMP or
inseminated date plus 14 days. If the first day of the LMP
was missing or if the menstrual cycle was irregular, these
pregnancies were excluded from this analysis.TheGA ranged
from 7+5 to 14+5 weeks.
The 3D volumes were converted to Cartesian volumes,
using 3D software (4D View, GE Medical Systems, Zipf,
Austria), and transferred to the BARCO (Kortrijk, Belgium)
I-Space VR system at the department of Bioinformatics of
Erasmus MC University Medical Center Rotterdam. This is
a four-walled CAVE like VR system in which investigators
are surrounded by stereoscopic images. A “hologram” of
the ultrasound data is created by the V-Scope [25] vol-
ume rendering application (Erasmus MC, Rotterdam, the
Figure 1: 3D transvaginal ultrasound dataset of a fetus with an
ectrodactyly ectodermal dysplasia-cleft (EEC) syndrome visualized
in Virtual Reality. Bilateral split hands and split feet are seen as well
as bilateral cheilognatoschisis. An overriding aorta with a ventricle
septum defect was diagnosed additionally.
Netherlands) and polarized glasses enable the viewer to
perceive depth and to interact with 3D volumes in an intuitive
manner. In the I-Space all 3D ultrasound volumes were
evaluated and the best volume for each case was selected
based on image quality and completeness of the volume. A
fetus with structural congenital abnormalities visualized in
Virtual Reality is shown in Figure 1.
CRL and EV were measured in the BARCO I-Space
using theV-Scope software.TheV-Scope application includes
a region-growing segmentation algorithm combined with
a neighbourhood variation threshold for semiautomatica
volume calculation in selected structures [25].The procedure
for measuring EV is described in detail by Rousian et al. [15]
The innovative VR technique has already been successfully
applied in various prenatal studies [14, 25].
To include all body parts of the embryo, the omphalo-
cele, physiological or pathological, is included in the EV
calculation, as well as hydrops, frequently present in fetuses
with structural congenital abnormalities. All measurements
were performed by the same investigator (LB). The accuracy
and reproducibility of CRL and EVmeasurements have been
proven in previous studies and CRL and EV reference curves
have been established [15, 26–28]. Inter- and intraobserver
variability for 3D-VR measurements were very high for CRL
(ICC 1.000; 95% CI: 0.999–1.000, resp., ICC 1.000; 95% CI:
0.999–1.000) as well as for EV measurements (ICC 0.999;
95% CI: 0.997–0.999, resp., 0.999; 95% CI: 0.998–0.999) [27,
29]. The data of the present study are compared with these
reference curves.
This study has been approved by the Central Committee
on Research inThe Hague and the Local Medical Ethical and
Institutional Review Board of the ErasmusMC (METC2004-
227).
2.1. Statistical Analysis. In each pregnancy complicated by a
congenital abnormality the observed values for CRL and/or
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Figure 2: CRL (𝑛 = 56) and EV (𝑛 = 51) of all cases with structural congenital abnormalities plotted relative to the reference curves for
healthy pregnancies.
EV were subtracted from the expected mean of CRL and
EV for GA. This expected value was obtained from reference
curves published in earlier studies [15, 26–29].This difference
was divided by the standard deviation (SD) for GA of the
reference values in order to obtain the 𝑧-score.This difference
was as well expressed as a percentage of the mean CRL and
EV of reference fetuses. When different ultrasound volumes
of different GAwere present, the dataset of the oldest GAwas
used. The same analysis was performed when the expected
value for EV was corrected for the measured CRL.
The one-sample two-sided 𝑡-test was used to test for a
statistically significant difference in 𝑧-score as compared to
the reference value.This analysis was performed in the overall
group of cases with structural congenital abnormalities and
in the different subgroups of various structural congenital
abnormalities.
Data analysis was performed using SPSS v.21 (SPSS
Inc., Chicago, IL, USA). A 𝑝 value < 0.05 was considered
statistically significant.
3. Results
Three cases were excluded from the analysis because of
uncertain GA and one because of a twin pregnancy. We
excluded 11 cases for the measurements of both CRL and
EV due to poor image quality caused by an intermediate
position of the uterus or movement artifacts (𝑁 = 9), due to
incompleteness of the volume (𝑁 = 1) and because of absence
of heartbeat at the time of the ultrasound scan (𝑁 = 1). A
total of 56 cases remained for analysis of CRL. As in five of
these cases the image quality was too poor for performing EV
measurement; only 51 cases remained for analysis of EV. Of
these 7 of 56 cases were conceived by artificial reproductive
techniques, 4 using ICSI, 2 using IVF, and 1 using IUI.
In the overall group of fetuses with structural congenital
abnormalities the EV was smaller than expected for GA
(−35% 𝑝 < 0.001, 𝑧-score −1.44 𝑝 < 0.001), whereas CRL
was not smaller than expected (−6.43% 𝑝 = 0.118, 𝑧-score
−0.43 𝑝 = 0.605). In 15 out of the 56 cases (26,8%) with
structural abnormalities theCRLwasmore than two standard
deviations below the mean (a 𝑧-score > −1,64). In 18 out of 51
cases (35,3%) the EV was more than two standard deviations
below the mean. The CRL was significantly smaller in the
subgroups with urogenital abnormalities and in the sub-
group with hydropic abnormalities. The EV was significantly
smaller in the subgroup with cardiac abnormalities, gastroin-
testinal abnormalities, urogenital abnormalities, neurological
abnormalities, and in the group with hydropic abnormalities
(Table 1).
In Figure 2 CRL and EV of all cases with structural
congenital abnormalities are plotted in the reference curves
for pregnancies without structural congenital abnormalities.
In the supplemental figures the different groups of structural
congenital abnormalities are plotted separately on the ref-
erences curves for CRL and EV (Supplemental Figure 1 is
available online at https://doi.org/10.1155/2017/1953076).
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Table 1: Mean percentage difference and 𝑧-scores for CRL and EV in both the overall group of structural congenital abnormalities and in the
various subgroups.
Variable/congenital abnormality
Mean difference in
𝑛
%
(95% CI) 𝑝
∗ 𝑧-score
(95% CI) 𝑝
∗
CRL
Overall 56 −6.43 (−14.55, 1.69) 0.118 −0.46 (−2.21, 1.30) 0.605
Craniofacial 2 −0.60 (−50.36, 49.15) 0.903 −0.05 (−6.25, 6.15) 0.931
Cardiac 5 −5.03 (−16.46, 6.39) 0.288 −1.34 (−2.27, 0.90) 0.296
Skeletal/muscles 8 −3.02 (−18.58, 12.54) 0.660 −0.55 (−2.62, 1.51) 0.547
Gastrointestinal 15 −7.02 (−18.05, 4.02) 0.194 −1.08 (−2.44, 0.28) 0.111
Urogenital 5 −4.98 (−7.87, −2.09) 0.009 −0.64 (−1.04, −0.25) 0.010
Neurological 14 0.12 (−30.53, 30.77) 0.993 1.59 (−5.74, 8.94) 0.646
Hydrops 7 −26.89 (−43.26,
−8.51) 0.011 −2.94 (−5.18, −0.71) 0.018
EV
Overall 51 −34.91 (−41.97,
−27.85) <0.001 −1.44 (−1.71, −1.16) <0.001
Craniofacial 2 −21.22 (−187.3,144.85) 0.351 −1.00 (−8.73, 6.73) 0.349
Cardiac 5 −31.86 (−56.43,
−7.28) 0.023 −1.34 (−2.30, −0.39) 0.017
Skeletal/muscles 6 −26.18 (−60.67, 8.30) 0.108 −0.92 (−2.21, 0.37) 0.127
Gastrointestinal 13 −35.78 (−49.45,
−22.11) <0.001 −1.53 (−2.09, −0.96) <0.001
Urogenital 4 −16.26 (−25.21,
−7.31) 0.010 −0.75 (−1.22, −0.27) 0.016
Neurological 14 −43.24 (−59.20,
−27.28) <0.001 −1.70 (−2.27, −1.13) <0.001
Hydrops 7 −40.85 (−66.34,
−15.36) 0.008 −1.76 (−2.88, −0.64) 0.008
∗It is for observed mean difference versus 0.
In Table 2 the percentage difference and 𝑧-score for
observed versus expected EV after correction for the
observed CRL is presented. No statistical differences were
found.
4. Discussion
To the best of our knowledge this is the first study that
investigates the relationship between EV and first-trimester
structural congenital abnormalities. Although overall the
CRL was not significantly smaller in fetuses with structural
congenital abnormalities, a smaller than expected CRL was
observed in hydropic fetuses and fetuses with urogenital
abnormalities. In contrast to CRL, EV was statistically
significant smaller than expected in the overall group of
structural congenital abnormalities. In all subgroups, except
for those with craniofacial and skeletal/muscle abnormalities,
we found a significantly smaller EV than expected.
The mean difference in EV was more evident than
the mean difference in CRL and went up to −43% (𝑧-
score −1.70) in fetuses with neurological abnormalities. This
can be explained by the fact that a volume is a three-
dimensional measurement in contrast to CRL, which is
a flat, two-dimensional distance measurement. It was already
demonstrated by Rousian et al. that when the CRL doubles
EV increases 6.5 times [15]. However, after correcting the
EV for the measured CRL significant differences were no
longer present, suggesting proportional growth restriction.
EV turned out to be a better parameter to detect first-
trimester growth restriction as compared with CRL.
From the literature it has recently become evident that
a detailed anatomical scan can be successfully preformed at
the end of the first-trimester.Themajority ofmajor structural
congenital abnormalities can therefore be diagnosed between
11 and 14 weeks GA. EV measurements can be performed
from 6 weeks GA onwards [15] andmay therefore possibly be
used as a marker of an underlying abnormality long before
an early anomaly scan can be performed. EV measurements
in early pregnancy might point a clinician to the increased
risk of a congenital abnormality. The effectiveness of EV as
a marker for structural congenital abnormalities should be
subject of further study.
The combination of early growth restriction and the
presence of structural congenital abnormalities might be due
to underlying pathological mechanisms. Growth restriction
might either occur as a result of a structural congenital
BioMed Research International 5
Table 2: The mean percentage differences and 𝑧-scores for EV after correction for the observed CRL both in the overall group of structural
congenital abnormalities and the subgroups of structural congenital abnormalities.
Variable/congenital abnormality
Mean difference in
𝑛
%
(95% CI) 𝑝
∗ 𝑧-score
(95% CI) 𝑝
∗
EV
Overall 51 27.86 (−14.34, 70.05) 0.191 0.92 (−0.66, 2.49) 0.247
Craniofacial 2 −6.18 (−266.27, 253.92) 0.813 −0.40 (−11.64, 10.84) 0.730
Cardiac 5 2.90 (−11.97, 17.76) 0.617 −0.10 (−0.71, 0.51) 0.673
Skeletal/muscles 6 29.69 (−71.29, 130.66) 0484 0.88 (−3.07, 4.82) 0.591
Gastrointestinal 13 14.94 (−4.72, 34.60) 0.124 0.47 (−0.38, 1.31) 0.254
Urogenital 4 4.95 (−2.93, 12.82) 0.139 0.008 (−27.34, 28.98) 0.932
Neurological 14 −1.82 (−25.66, 22.03) 0.872 −0.12 (−1.11, 0.87) 0.798
Hydrops 7 150.26 (−211.03, 511.54) 0.348 5.50 (−7.89, 18.89) 0.354
∗It is for observed mean difference versus 0.
abnormality or growth restriction and structural congenital
abnormalities might have a common etiological factor.
Limitations of the study are the low numbers of included
cases with structural congenital abnormalities. Still finding
significant differences for EV suggests a strong relationship
of first-trimester structural congenital abnormalities and a
decreased EV. Therefore, increasing the numbers in future
studies will most likely only strengthen this relationship.
Pregnancies with known chromosomal abnormalities were
not included in the study. As fetal karyotypingwas performed
in 36 of 56 cases; it may be possible that cases with a chro-
mosomal abnormality in our study group remained unno-
ticed. However, in all but 5 cases with an increased nuchal
translucency, hygroma colli or hydrops fetalis, karyotyping
was performed and showed to be euploid. The five cases with
an increased nuchal translucency, hygroma colli or hydrops
fetalis, were all in “hydrops” group and either spontaneously
miscarried or were terminated before karyotyping could be
performed.
We included pregnancies conceived by artificial repro-
ductive techniques in our series of cases with structural con-
genital abnormalities. Recent studies point out that growth
trajectories in early pregnancy do not differ between spon-
taneously conceived pregnancies and pregnancies conceived
using artificial reproductive techniques in our population
[30].
Furthermore, the BARCO I-Space is too large and too
expensive to become a routine method for the measurement
of EV. However, a much smaller and more affordable 3D VR
desktop system is currently being evaluated and will provide
a good alternative, making this technique broadly available
to hospitals [31]. Following the introduction of the desktop
VR system we foresee implementation of VR as an option in
ultrasound machines in the near future.
We are aware that 3D ultrasound and its calculating
software, that is, 4D view, are widely available for volume
calculations, in contrast to the VR technique. However, using
the available software on the ultrasound machine requires
delineating the contours of the embryo manually in several
different planes, which is subject to individual variation. The
semiautomatic approach of the I-Space and its true depth per-
ception allow for more objective volume measurements and
prevent incomplete segmentations. Another advantage of the
VR technique is that thewhole body volume ismeasuredwith
this technique, whereas when using the manual delineating
technique only a head and trunk volume can be calculated,
resulting in an underestimation.
5. Conclusions
In conclusion, CRL, the current golden standard for the
detection of first-trimester growth restriction, seems a less
reliable parameter to detect growth restriction in fetuses
with structural congenital abnormalities as compared with
EV, being significantly decreased in these pregnancies. By
measuring EV, first-trimester growth restriction becomes
more evident and might enable an earlier detection of cases
at risk for a congenital abnormality.
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